Disease/Infection News

RSS

NanoBio Corporation receives U.S. patent for nanoemulsion technology

NanoBio Corporation announced today that it has been awarded a seventh U.S. patent covering its novel nanoemulsion technology. The new claims encompass methods of treating Herpes Simplex I infections, including herpes labialis (commonly referred to as cold sores), using NanoBio's proprietary anti-infective nanoemulsion product candidates.

5 Aug 2010

Foldit players to focus on designing novel proteins

Computer scientists and biochemists at the University of Washington two years ago launched an ambitious project harnessing the brainpower of computer gamers to solve medical problems. The game, Foldit, turns one of the hardest problems in molecular biology into a game a bit reminiscent of Tetris. Thousands of people have now played a game that asks them to fold a protein rather than stack colored blocks or rescue a princess.

5 Aug 2010

FDA issues Lux Biosciences Complete Response letter for Luveniq NDA

Lux Biosciences, Inc. today announced that the U.S. Food and Drug Administration's Center of Drug Evaluation and Research has issued a Complete Response letter regarding the New Drug Application (NDA) for Luveniq™ (oral voclosporin) for the treatment of non-infectious uveitis.

5 Aug 2010

Scientists invent Global Focus microscope for tuberculosis diagnosis

A compact microscope invented at Rice University is proving its potential to impact global health. In a paper published online today in the journal PLoS ONE, Rice alumnus Andrew Miller and co-authors show that his portable, battery-operated fluorescence microscope, which costs $240, stacks up nicely against devices that retail for as much as $40,000 in diagnosing signs of tuberculosis.

5 Aug 2010

Acceleron's ACE-031 protein therapeutic for DMD receives FDA Fast Track designation

Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced it received FDA Fast Track designation for ACE-031 for the treatment of Duchenne Muscular Dystrophy (DMD), a fatal neuromuscular disease in which patients suffer from the progressive loss of muscle mass and strength. ACE-031 is an investigational protein therapeutic being developed to increase muscle mass and strength.

5 Aug 2010

PCV-7 vaccine introduction leads to changing patterns of hemolytic uremic syndrome

Introduction of the PCV-7 vaccine to prevent invasive pneumococcal disease (IPD) has led to a shift in the types of bacteria causing hemolytic uremic syndrome (HUS)—an important cause of acute kidney failure in children, reports a study in the August issue of The Pediatric Infectious Disease Journal.

4 Aug 2010

WHO provides medicines, related health supplies to flood-affected areas in Pakistan

The worst floods on record in Pakistan are placing the health of hundreds of thousands of people at risk, with a high threat of waterborne disease outbreaks and immense damage to health facilities. WHO is coordinating the response of health partners and supporting Pakistani authorities by sending medicines and related health supplies capable of treating more than 200 000 people to the affected areas in the northwestern region of the country.

4 Aug 2010

Prairie dog study holds significant implications for understanding spread of infectious diseases

Prairie dogs, once abundant in the Rocky Mountains and Great Plains, have been decimated in recent decades by plague - a virulent bacterial disease spread by fleas.Plague outbreaks periodically sweep through large prairie dog towns with thousands of inhabitants, killing virtually the entire population within months. Other prairie dogs move in and build a new colony, which eventually is wiped out when the disease returns.

4 Aug 2010

ICU Medical's Neutron Neutral-Pressure Needleless Connector receives FDA clearance

ICU Medical, Inc., a worldwide leader in the development, manufacture and sale of proprietary, disposable medical connection systems for use in vascular therapy applications, today confirmed that it has received FDA 510-k clearance for the Neutron™ Neutral-Pressure Needleless Connector.

4 Aug 2010

Opinions: AIDS 2010; Clean water, sanitation; Russia's HIV/AIDS epidemic; Financial tax; Medical abortion in developing countries

A VOA News editorial by the U.S. government reflects on last month's International AIDS Conference-AIDS 2010, including key advancements such as the vaginal microbicide gel found to offer women some protection against HIV infection as well discussions about funding for the fight against HIV/AIDS and how the "criminalization of drug abuse and persecution of homosexuals" in the world is compromising efforts to prevent the spread of the disease.

4 Aug 2010

AHF praises NJ for saving drug program, criticizes BMS for refusal to cut prices for ADAPs

AIDS Healthcare Foundation (AHF) lauded innovative New Jersey state health officials who were able to keep providing nearly 1,000 AIDS patients throughout the state with access to lifesaving antiretroviral medications with an 11th hour fix to a struggling state AIDS drug distribution program that was set to cut them from the program's eligibility rolls as of Sunday, August 1st.

3 Aug 2010

U.S. Department of Justice seeks permanent injunction against N.Y. food processor over listeria contamination

The U.S. Department of Justice, in an action initiated by the U.S. Food and Drug Administration, is seeking a permanent injunction against NY Gourmet Salads, Inc., a processor of ready-to-eat deli salads, seafood salads, and cream cheeses in Brooklyn, N.Y., and Leonard F. Spada, the company's president.

3 Aug 2010

An overview of ESA-s Annual Meeting

Whether it is a single rock being overturned or an entire mountaintop being removed, humans play a continuous role in environmental processes, and vice versa. Ecological scientists will discuss findings on human-ecosystem interactions-from the effects of nanomaterials on plant growth to the diversity of insect species on green roofs, and even communities of airborne microbes in hospital buildings-at the Ecological Society of America's 95th Annual Meeting in Pittsburgh from August 1-6, 2010. Here is just some of the research on humans and the environment to be presented:

3 Aug 2010

Telormedix, Swiss TPH Institute collaborate to develop effective vaccines for Malaria, Buruli Ulcer

Telormedix, a clinical stage biopharmaceutical company using targeted immunity to treat cancer and other diseases, today announced the start of a collaboration with the Swiss Tropical and Public Health Institute (Swiss TPH) on a pilot study using Telormedix's adjuvant, TMX-201, in connection with immunization for Malaria and Buruli Ulcer.

3 Aug 2010

FDA approves N30 Pharma's NDA for N6022 GSNOR

N30 Pharmaceuticals, LLC today announced the approval of its Investigational New Drug Application for N6022 by the U.S. Food and Drug Administration. N6022, a first-in-class inhibitor of s-nitrosoglutathione reductase (GSNOR), has the potential to be an important new treatment for acute exacerbations of asthma, chronic obstructive pulmonary disease (COPD) and inflammatory bowel disease (IBD).

3 Aug 2010

Methods to boost neutralizing antibody may prevent HIV-1 transmission

Monkeys repeatedly immunized with a particular form the HIV-1 envelope glycoprotein generated antibodies capable of neutralizing diverse strains of HIV-1, according to a paper published online in the Journal of Experimental Medicine on August 2.

3 Aug 2010

Survey on administrating human papillomavirus vaccine for cervical cancer prevention

The vast majority of pediatricians and family physicians nationally are offering the human papillomavirus (also called HPV) vaccine, though fewer physicians are strongly encouraging it for 11- to 12-year-old girls as recommended by national guidelines, according to a survey in the September issue of Pediatrics, the journal of the American Academy of Pediatrics.

3 Aug 2010

East Africa declared polio-free again after outbreak

"Eastern Africa is free of polio again, with four countries - Ethiopia , Kenya, Sudan and Uganda - having reported no cases of the crippling disease for more than a year, U.N. and other aid agencies said on Friday," Reuters reports (7/30). The WHO "said the region had responded fast to the outbreak," according to the Daily Monitor. The article reports that the four countries now "join neighbouring Somalia which has been polio free for the last three years" (Lirri, 8/2).

3 Aug 2010

Alphavirus vaccine blocks tumor growth in advanced cancer: Research

An experimental vaccine based on a virus that causes encephalitis in the wild appears to block tumor growth in some cases of advanced cancer, according to researchers at Duke University Medical Center. Scientists say the vaccine is able to stimulate an immune response, even in the face of profound immune system suppression, a condition most patients with advanced cancer experience.

3 Aug 2010

Researchers develop techniques to identify evolution of drug resistance strains of malaria

Researchers at Case Western Reserve University developed techniques to quickly identify evolution of drug resistance in strains of malaria. Their goal is to enable the medical community to react quickly to inevitable resistance and thereby save lives while increasing the lifespan of drugs used against the disease.Currently, disease monitoring requires months of clinical trials. The new methods can provide more information in just days, and far cheaper.

3 Aug 2010

Disease/Infection News

NanoBio Corporation receives U.S. patent for nanoemulsion technology

Foldit players to focus on designing novel proteins

FDA issues Lux Biosciences Complete Response letter for Luveniq NDA

Scientists invent Global Focus microscope for tuberculosis diagnosis

Acceleron's ACE-031 protein therapeutic for DMD receives FDA Fast Track designation

PCV-7 vaccine introduction leads to changing patterns of hemolytic uremic syndrome

WHO provides medicines, related health supplies to flood-affected areas in Pakistan

Prairie dog study holds significant implications for understanding spread of infectious diseases

ICU Medical's Neutron Neutral-Pressure Needleless Connector receives FDA clearance

Opinions: AIDS 2010; Clean water, sanitation; Russia's HIV/AIDS epidemic; Financial tax; Medical abortion in developing countries

AHF praises NJ for saving drug program, criticizes BMS for refusal to cut prices for ADAPs

U.S. Department of Justice seeks permanent injunction against N.Y. food processor over listeria contamination

An overview of ESA-s Annual Meeting

Telormedix, Swiss TPH Institute collaborate to develop effective vaccines for Malaria, Buruli Ulcer

FDA approves N30 Pharma's NDA for N6022 GSNOR

Methods to boost neutralizing antibody may prevent HIV-1 transmission

Survey on administrating human papillomavirus vaccine for cervical cancer prevention

East Africa declared polio-free again after outbreak

Alphavirus vaccine blocks tumor growth in advanced cancer: Research

Researchers develop techniques to identify evolution of drug resistance strains of malaria

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News